:

What drugs are used in bridging therapy?

Across the globe, millions of patients on long-term anticoagulant therapy must temporarily stop their medication for surgery or invasive procedures. This interruption creates a risk of dangerous blood clots, necessitating bridging therapy with short-acting agents. Additionally, the term “bridging therapy” also refers to specific cancer treatments, such as those used for multiple myeloma, to control disease progression while awaiting CAR T-cell infusion.